The ABC transporter genes of Plasmodium falciparum and drug resistance

Drug Resistance Updates

Volumn 4, Issue 1, 2001, Pages 66-74

  Peel, Sheila A ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ALKALOID; AMLODIPINE; AMODIAQUINE; AMOXAPINE; ANTIESTROGEN; ANTIMALARIAL AGENT; ARTEMISININ; ARTESUNATE; CALCIUM ANTAGONIST; CHLOROQUINE; CHLORPHENIRAMINE; CHLORPROMAZINE; CYPROHEPTADINE; DESIPRAMINE; DILTIAZEM; DOXEPIN; FLUOXETINE; GALLOPAMIL; GLYCOPROTEIN P; HALOFANTRINE; IMIPRAMINE; MAPROTILINE; MEFLOQUINE; MEPACRINE; NORFLUOXETINE; PROTRIPTYLINE; QUININE; QUINOLINE DERIVATIVE; SERTRALINE; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VERAPAMIL;

ANTIBIOTIC RESISTANCE; GENE ISOLATION; HUMAN; MALARIA; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY;

EID: 0035065294     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.2001.0183     Document Type: Article

References (106)

1. Malaria, the submerged disease
2. Susceptibility of human malaria parasites to chloroquine is pH dependent
3. Simulation of kinetic data on the influx and efflux of chloroquine by erythrocytes infected with Plasmodium falciparum. Evidence for a drug-importer in chloroquine-sensitive strains
4. On the molecular mechanism of chloroquine's antimalarial action
5. Chloroquine resistance in Plasmodium falciparum
6. Chloroquine resistance in Plasmodium falciparum in Thailand
7. Chemotherapy and drug resistance in malaria
8. Cloning and characterization of mefloquine resistant Plasmodium falciparum from Thailand
9. Innate resistance to new antimalarial drugs in Plasmodium falciparum from Nigeria
10. Mefloquine-resistant falciparum malaria on the Thai-Burmese border
11. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria
12. Efflux of chloroquine from Plasmodium falciparum: Mechanism of chloroquine resistance
13. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil
14. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum
15. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum
16. Characterization of the pfmdr2 gene for Plasmodium falciparum
17. Cloning and sequence analysis of a novel member of the ATP-binding cassette (ABC) protein gene family from Plasmodium falciparum
18. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance, and bacterial transport
19. ABC transporters; from microorganisms to man
20. Isolation and expression of a complementary DNA that confers multidrug resistance
21. An inventory of human ABC proteins
22. Multidrug resistance - A fascinating, clinically relevant problem in bioenergetics
23. Photoaffinity analogs for multidrug resistance-related transporters and their use in identifying chemosensitizers
24. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitizers
25. Using purified P-glycoprotein to understand multidrug resistance
26. Multidrug resistance and chemosensitization: Therapeutic implication for cancer chemotherapy
27. A comparison of the phenomenology and genetics of multidrug resistance in cancer cells and quinoline resistance in Plasmodium falciparum
28. Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine
29. Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum
30. Plasmodium falciparum: Modulation by calcium antagonists of resistance to chloroquine, desethylchloroquine, quinine, and quinidine in vitro
31. In vitro and in vivo potentiation of chloroquine resistant against malaria parasites by an enantiomer of amlodipine
32. Fluoxetine hydrochloride enhances in vitro susceptibility to chloroquine in resistant Plasmodium falciparum
33. In vitro reversal of chloroquine resistance with chlorpheniramine against African isolates of Plasmodium falciparum
34. Physicochemical properties correlated with drug resistance and the reversal of resistance in Plasmodium falciparum
35. Enhancement of antimalarial effect of chloroquine on drug resistant parasits strains: A critical-examination of the reversal of multidrug resistance
36. Reversal of mefloquine resistance with penfluridol in isolates of Plasmodium falciparum from south-west Nigeria
37. Modulation of the function of human MDRI P-glycoprotein by the antimalarial drug mefloquine
38. The pfmdr1 gene is associated with a multidrug resistant phenotype in Plasmodium falciparum from the western border of Thailand
39. Multidrug resistance and P-glycoproteins in parasitic protozoa
40. Stage-specific transcripts of the Plasmodium falciparum pfmdr1 gene
41. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole
42. Nucleotide binding properties of a P-glycoprotein homologue from Plasmodium falciparum
43. Phosphorylation of a P-glycoprotein homologue in Plasmodium falciparum
44. Selection for high-level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum
45. A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro
46. The ATP-binding cassette (ATP) gene family of Plasmodium falciparum
47. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum
48. Analysis of pfmdr1 and drug susceptibility in fresh isolates of Plasmodium falciparum from sub-Saharan Africa
49. Pfmdr1 mutations and chloroquine-resistance in Plasmodium falciparum isolates from Zaire, Nigeria
50. Assessment of the association between three pfmdr1 point mutations and chloroquine resistance in vitro of Malaysian Plasmodium falciparum isolates
51. Guinea Bissua: Association of chloroquine resistance of Plasmodium falciparum with the Tyr86 allele of the multiple drug-resistant gene Pfmdr1
52. Plasmodium falciparum mdr1 mutations and in vivo chloroquine resistance in Indonesia
53. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the antimalarials mefloquine and artemisinin
54. Chloroquine-resistant Plasmodium falciparum isolates from the Sudan lack two mutations in the pfmdr1 gene thought to be associated with chloroquine resistance
55. Pfmdr1 asn 1042Asp and Asp1246Try polymorphisms thought to be associated with chloroquine resistance, are present in chloroquine-resistant and sensitive Brazilian field isolates of Plasmodium falciaprum
56. Plasmodium falciparum: Characterization of multidrug-resistant Cambodian isolates
57. Phenotypic and genotypic characteristics of recently adapted isolateds of Plasmodium falciparum
58. Analysis of mefloquine resistance and amplification of pfmdr1 in multidrug-resistant Plasmodium falciparum isolates from Thailand
59. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross
60. Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7
61. Chromosomes of malaria parasites
62. Complex polymorphisms in a ∼ 330 kDa protein are linked to chloroquine resistant P. falciparum in Southeast Asia and Africa
63. Transfection based studies defining the chloroquine resistance determinant in Plasmodium falciparum
64. Identification of a Plasmodium falciparumgene (PFCRT) encoding a putative membrane protein linked to chloroquine resistance
65. Mutation sin the P. falciparum digestive vacuole transmembrane protein PFCRT and evidence for their role in chloroquine resistance
66. Amplification of pfmdr1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand
67. Derivation of highly mefloquine-resistant lines from Plasmodium falciparum in vitro
68. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine
69. In vitro selection of halofantrine resistance in Plasmodium falciparum in not associated with increased expression of Pgh1
70. Amplification of the multidrug resistance gene pfmdr1 in Plasmodium falciparum has arisen as multiple independent events
71. Analysis of mefloquine resistance and amplification of pfmdr1 in multidrug-resistant Plasmodium falciaprum isolates from Thailand
72. Plasmodium falciparum amplification and overexpression of pfmdr1 is not necessary for mefloquine resistance
73. Expression of the plasmodial pfmdr1 gene in mammalian cells is associated with increased susceptibility to chloroquine
74. Enhanced lysosomal acidification leads to increased chloroquine accumulation in CHO cells expressing the pfmdr1 gene
75. Modulatory effects on substrate specificity of independent mutations at the serine 939/941 position in predicted transmembrane domain 11 of P-glycoproteins
76. Defective acidification of intracellular organelles in cystic fibrosis
77. Volume-regulated chloride channels associated with the human multidrug resistance P-glycorprotein
78. Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: Further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein
79. Identification of a chloroquine improter in Plasmodium falciparum. Differences in import kinetics are genetically linked with the chloroquine-resistant phenotype
80. Differential stimulation of the Na+/H+ exchanger determines chloroquine uptake in Plasmodium falciparum
81. Functional complementation of the ste6 gene of Saccharomyces cerevisiae with the pfmdr1 gene of Plasmodium falciparum
82. Functional complementation of yeast ste6 by a mammalian multidrug resistance mdr gene
83. Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast
84. Functional expression of P-glycoprotein in Saccharomyces cerevisiae confers cellular resistance to the immunosupproessive and antifungal agent FK520
85. The pfmdr1 gene of Plasmodium falciparum confers cellular resistance to antimalarial drugs in yeast cells
86. Pharmacolcogy
87. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine
88. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
89. Transcripts of the multidrug resistance genes in chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum
90. Plasmodium falciparum, the pfmdr2 protein is not overexpressed in chloroquine-resistant isolates of the malaria parasite
91. The human malarial parasite Plasmodium falciparum exprots the ATP-binding cassette protein PFGCN20 to membrane structures in the host red blood cell
92. Protein transport in the host cell cytoplasm and ATP-binding cassette proteins in Plasmodium falciparum-infected erythrocytes
93. Multidrug resistant falciparum malaria in Cameroon in 1987-1988. 1. Stable figures of prevalence of chloroquine- and quinine-resistant isolates in the original foci
94. Physical-chemical properties shared by compounds that modulate multidrug resistance in human-leukemic cells
95. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
96. Shotgun DNA microarrays and stage-specific gene expression in Plasmodium falciparum malaria
97. Drug target validation and indentification of secondary drug target effects using DNA microarrays
98. Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants
99. Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis durg CPX using genome microarray analysis
100. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization
101. Antisense RNA gene therapy for studying and modulating biological processes
102. Transdominant genetic analysis of a growth control pathway
103. Ribozymes, genomics and therapeutics
104. The impact of two-hybrid and related methods on biotechnology
105. Aptamers as therapeutic and diagnostic reagents: Problems, and prospects